Do we need gastric acid?

Digestion

Volumn 77, Issue 3-4, 2008, Pages 184-197

  Pohl, D ^a   Fox, M ^a   Fried, M ^a   Goke B ^b   Prinz, C ^c   Monnikes H ^d   Rogler, G ^a   Dauer, M ^b   Keller, J ^e   Lippl, F ^b   Schiefke, I ^f   Seidler, U ^g   Allescher, H D ^h  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

^e ISRAELITISCHES KRANKENHAUS   (Germany)

^f UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^g HANNOVER MEDICAL SCHOOL   (Germany)

^h Klinikum Garmisch Partenkirchen   (Germany)

Author keywords

Acid suppression; Clostridium difficile; Gastric acid secretion; Gastric emptying; Gastric motility; Ghrelin; Helicobacter pylori; Metabolism, neuroendocrine; Proton pump inhibitors; Satiety

Indexed keywords

ANTIANEMIC AGENT; CALCIUM ION; CIMETIDINE; GASTRIN; GASTROINTESTINAL HORMONE; GASTROINTESTINAL POLYPEPTIDE; GHRELIN; OMEPRAZOLE; RANITIDINE;

ATROPHIC GASTRITIS; BACTERIAL OVERGROWTH; CALCIUM ABSORPTION; DIGESTION; DRUG MEGADOSE; FEEDING BEHAVIOR; GASTROINTESTINAL INFECTION; GASTROINTESTINAL MOTILITY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HORMONE ACTION; HUMAN; HUNGER; INTESTINE FLORA; LIPID METABOLISM; MICROBIOLOGY; MOOD; MUCOSA; NEUROENDOCRINE SYSTEM; NONHUMAN; PATHOPHYSIOLOGY; PERISTALSIS; PRIORITY JOURNAL; PROTEIN METABOLISM; PSYCHOLOGICAL ASPECT; REVIEW; SATIETY; SMALL INTESTINE; STOMACH; STOMACH ACID; STOMACH ACID SECRETION; STOMACH EMPTYING; STOMACH EPITHELIUM;

AMYLOID; ANIMALS; CALCIUM; EPITHELIUM; FEEDING BEHAVIOR; GASTRIC ACID; GASTRIC EMPTYING; GASTRITIS; GASTROENTERITIS; GASTROINTESTINAL MOTILITY; GHRELIN; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINAL ABSORPTION; IRON, DIETARY; SATIATION; SECRETIN; SOMATOSTATIN; STOMACH; STRESS, PSYCHOLOGICAL;

EID: 50149109006     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000142726     Document Type: Review

References (190)

1. Blum AL, Hegglin J, Krejs GJ, Largiader F, Sauberli H, Schmid P: Gastric emptying of organic acids in the dog. J Physiol 1976;261:285-299.
2. Holzer P, Painsipp E, Schuligoi R: Differential effects of intragastric acid and capsaicin on gastric emptying and afferent input to the rat spinal cord and brainstem. BMC Neurosci 2005;6:60.
3. Lin HC, Doty JE, Reedy TJ, Meyer JH: Inhibition of gastric emptying by acids depends on pH, titratable acidity, and length of intestine exposed to acid. Am J Physiol 1990;259:G1025-G1030.
4. Raybould HE, Holzer HH: Duodenal acid-induced inhibition of gastric motility and emptying in rats. Am J Physiol 1993;265:G540-G546.
5. Lu YX, Owyang C: Duodenal acid-induced gastric relaxation is mediated by multiple pathways. Am J Physiol 1999;276:G1501-G1506.
6. Tucci A, Poli L, Biasco G, et al: Helicobacter pylori infection and gastric function in patients with fundic atrophic gastritis. Dig Dis Sci 2001;46:1573-1583.
7. Malagelada JR: Pathophysiological responses to meals in the Zollinger-Ellison syndrome. 2. Gastric emptying and its effect on duodenal function. Gut 1980;21:98-104.
8. Hunt JN, Stubbs DF: The volume and energy content of meals as determinants of gastric emptying. J Physiol 1975;245:209-225.
9. Mangnall YF, Kerrigan DD, Johnson AG, Read NW: Applied potential tomography. Noninvasive method for measuring gastric emptying of a solid test meal. Dig Dis Sci 1991;36:1680-1684.
10. Woodtli W, Owyang C: Duodenal pH governs interdigestive motility in humans. Am J Physiol 1995;268:G146-G152.
11. Bortolotti M, Barbara L: Interdigestive gastroduodenal motor activity in subjects with increased gastric acid secretion. Digestion 1988;41:156-160.
12. Jones MP, Shah D, Ebert CC: Effects of rabeprazole sodium on gastric emptying, lectro-gastrography, and fullness. Dig Dis Sci 2003;48:69-73
13. Camilleri M, Hasler WL, Parkman HP, Quigley EM, Soffer E: Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology 1998;115:747-762.
14. Sorensen M, Tetzschner T, Rasmussen OO, Christiansen J: Relation between electromyography and anal manometry of the external anal sphincter. Gut 1991;32:1031-1034.
15. Tougas G, Earnest DL, Chen Y, Vanderkoy C, Rojavin M: Omeprazole delays gastric emptying in healthy volunteers: an effect prevented by tegaserod. Aliment Pharmacol Ther 2005;22:59-65.
16. Mays EE, Dubois JJ, Hamilton GB: Pulmonary fibrosis associated with tracheobronchial aspiration. A study of the frequency of hiatal hernia and gastroesophageal reflux in interstitial pulmonary fibrosis of obscure etiology. Chest 1976;69:512-515.
17. Benini L, Castellani G, Bardelli E, et al: Omeprazole causes delay in gastric emptying of digestible meals. Dig Dis Sci 1996;41:469-474.
18. Forrest JA, Heading RC, Park J, et al: Effect of histamine H 2 -receptor blockade on gastric emptying and serum gastrin in man. Scott Med J 1976;21:23-27.
19. Rasmussen L, Oster-Jorgensen E, Qvist N, Kraglund K, Hovendal C, Pedersen SA: Short report: a double-blind placebo-controlled trial of omeprazole on characteristics of gastric emptying in healthy subjects. Aliment Pharmacol Ther 1991;5:85-89.
20. Horton JW, McClelland RN, Weger RV: Effect of parietal cell vagotomy on gastric emptying in duodenal ulcer disease. Am J Surg 1982;143:86-89.
21. Mistiaen W, Van Hee R, Blockx P, Hubens A: Gastric emptying for solids in patients with duodenal ulcer before and after highly selective vagotomy. Dig Dis Sci 1990;35:310-316.
22. Yu P, Wang D, Cai Z, Wen Y: Long-term clinical results after highly selective vagotomy plus pylorus-preserved mucosal antrectomy. Chin J Surg 2002;40:650-652.
23. Schmidt WE, Creutzfeldt W, Hocker M, et al: Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastroentero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion. Eur J Clin Invest 1991;21:501-511.
24. Chung I, Li P, Lee K, Chang T, Chey WY: Dual inhibitory mechanism of secretin action on acid secretion in totally isolated, vascularly perfused rat stomach. Gastroenterology 1994;107:1751-1758.
25. Shimizu K, Li P, Lee KY, Chang TM, Chey WY: The mechanism of inhibitory action of secretin on gastric acid secretion in conscious rats. J Physiol 1995;488:501-508.
26. Piqueras L, Tache Y, Martinez V: Galanin inhibits gastric acid secretion through a somatostatin-independent mechanism in mice. Peptides 2004;25:1287-1295.
27. Drucker DJ: Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology 2002;122:531-544.
28. Yang H: Central and peripheral regulation of gastric acid secretion by peptide YY. Peptides 2002;23:349-358.
29. Hildebrand P, Lehmann FS, Ketterer S, et al: Regulation of gastric function by endogenous gastrin releasing peptide in humans: studies with a specific gastrin releasing peptide receptor antagonist. Gut 2001;49:23-28.
30. Wettergren A, Petersen H, Orskov C, Christiansen J, Sheikh SP, Holst JJ: Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man. Scand J Gastroenterol 1994;29:501-505.
31. Wettergren A, Maina P, Boesby S, Holst JJ: Glucagon-like peptide-1 7-36 amide and peptide YY have additive inhibitory effect on gastric acid secretion in man. Scand J Gastroenterol 1997;32:552-555.
32. Wojdemann M, Wettergren A, Hartmann B, Hilsted L, Holst JJ: Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2. J Clin Endocrinol Metab 1999;84:2513-2517.
33. Meier JJ, Nauck MA, Pott A, et al: Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans. Gastroenterology 2006;130:44-54.
34. Lu S, Guan JL, Wang QP, et al: Immunocytochemical observation of ghrelin-containing neurons in the rat arcuate nucleus. Neurosci Lett 2002;321:157-160.
35. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-660.
36. Peeters TL: Ghrelin: a new player in the control of gastrointestinal functions. Gut 2005;54:1638-1649.
37. Dornonville de la Cour C, Lindstrom E, Norlen P, Hakanson R: Ghrelin stimulates gastric emptying but is without effect on acid secretion and gastric endocrine cells. Regul Pept 2004;120:23-32.
38. Sibilia V, Pagani F, Guidobono F, et al: Evidence for a central inhibitory role of growth hormone secretagogues and ghrelin on gastric acid secretion in conscious rats. Neuroendocrinology 2002;75:92-97.
39. 1a receptors in ghrelin inhibition of gastric acid secretion in the rat. J Neuroendocrinol 2006;18:122-128.
40. Masuda Y, Tanaka T, Inomata N, et al: Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 2000;276:905-908.
41. Levin F, Edholm T, Ehrstrom M, et al: Effect of peripherally administered ghrelin on gastric emptying and acid secretion in the rat. Regul Pept 2005;131:59-65.
42. Date Y, Nakazato M, Murakami N, Kojima M, Kangawa K, Matsukura S: Ghrelin acts in the central nervous system to stimulate gastric acid secretion. Biochem Biophys Res Commun 2001;280:904-907.
43. Brzozowski T, Konturek PC, Konturek SJ, et al: Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage. Regul Pept 2004;120:39-51.
44. Brzozowski T, Konturek PC, Sliwowski Z, et al: Prostaglandin/ cyclooxygenase pathway in ghrelin-induced gastroprotection against ischemia-reperfusion injury. J Pharmacol Exp Ther 2006;319:477-487.
45. Gnanapavan S, Kola B, Bustin SA, et al: The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002;87:2988.
46. Kojima M, Kangawa K: Ghrelin: structure and function. Physiol Rev 2005;85:495-522.
47. Barzon L, Pacenti M, Masi G, Stefani AL, Fincati K, Palu G: Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors. Oncology 2005;68:414-421.
48. Xu L, Depoortere I, Tomasetto C, et al: Evidence for the presence of motilin, ghrelin, and the motilin and ghrelin receptor in neurons of the myenteric plexus. Regul Pept 2005;124:119-125.
49. Moechars D, Depoortere I, Moreaux B, et al: Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor-knockout mouse. Gastroenterology 2006;131:1131-1141.
50. Lauwers E, Landuyt B, Arckens L, Schoofs L, Luyten W: Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem Biophys Res Commun 2006;351:21-25.
51. Tremblay F, Perreault M, Klaman LD, Tobin JF, Smith E, Gimeno RE: Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39. Endocrinology 2007;148:501-506.
52. Mulder H, Lindh AC, Ekblad E, Westermark P, Sundler F: Islet amyloid polypeptide is expressed in endocrine cells of the gastric mucosa in the rat and mouse. Gastroenterology 1994;107:712-719.
53. Zaki M, Koduru S, McCuen R, Vuyyuru L, Schubert ML: Amylin, released from the gastric fundus, stimulates somatostatin and thus inhibits histamine and acid secretion in mice. Gastroenterology 2002;123:247-255.
54. Rossowski WJ, Cheng BL, Jiang NY, Coy DH: Examination of somatostatin involvement in the inhibitory action of GIP, GLP-1, amylin and adrenomedullin on gastric acid release using a new SRIF antagonist analogue. Br J Pharmacol 1998;125:1081-1087.
55. Hirsch AB, McCuen RW, Arimura A, Schubert ML: Adrenomedullin stimulates somatostatin and thus inhibits histamine and acid secretion in the fundus of the stomach. Regul Pept 2003;110:189-195.
56. Li P, Chang TM, Coy D, Chey WY: Inhibition of gastric acid secretion in rat stomach by PACAP is mediated by secretin, somatostatin, and PGE(2). Am J Physiol 2000;278:G121-G127.
57. Sandvik AK, Cui G, Bakke I, Munkvold B, Waldum HL: PACAP stimulates gastric acid secretion in the rat by inducing histamine release. Am J Physiol 2001;281:G997-G1003.
58. Tornoe K, Hannibal J, Georg B, et al: PACAP 1-38 as neurotransmitter in the porcine antrum. Regul Pept 2001;101:109-121.
59. Pyrah LN, Smith IB: Osteomalacia following gastrectomy. Lancet 1956;270:935-937.
60. Mitchell AB, Glass D, Gill AM: Bone disease after gastrectomy. Br Med J 1972;2:164.
61. Heiskanen JT, Kroger H, Paakkonen M, Parviainen MT, Lamberg-Allardt C, Alhava E: Bone mineral metabolism after total gastrectomy. Bone 2001;28:123-127.
62. Eastell R, Vieira NE, Yergey AL, et al: Pernicious anaemia as a risk factor for osteoporosis. Clin Sci (Lond) 1992;82:681-685.
63. Yang YX, Lewis JD, Epstein S, Metz DC: Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006;296:2947-2953.
64. Champagne ET: Low gastric hydrochloric acid secretion and mineral bioavailability. Adv Exp Med Biol 1989;249:173-184.
65. Bronner F, Stein WD: Calcium homeostasis - an old problem revisited. J Nutr 1995;125:1987S-1995S.
66. Bronner F: Mechanisms and functional aspects of intestinal calcium absorption. J Exp Zoolog A Comp Exp Biol 2003;300:47-52.
67. Bronner F: Mechanisms of intestinal calcium absorption. J Cell Biochem 2003;88:387-393.
68. Bo-Linn GW, Davis GR, Buddrus DJ, Morawski SG, Santa Ana C, Fordtran JS: An evaluation of the importance of gastric acid secretion in the absorption of dietary calcium. J Clin Invest 1984;73:640-647.
69. Guinotte F, Gautron J, Nys Y, Soumarmon A: Calcium solubilization and retention in the gastrointestinal tract in chicks (Gallus domesticus) as a function of gastric acid secretion inhibition and of calcium carbonate particle size. Br J Nutr 1995;73:125-139.
70. Graziani G, Badalamenti S, Como G, et al: Calcium and phosphate plasma levels in dialysis patients after dietary Ca-P overload. Role of gastric acid secretion. Nephron 2002;91:474-479.
71. Graziani G, Como G, Badalamenti S, et al: Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects. Nephrol Dial Transplant 1995;10:1376-1380.
72. Marcelli D, Locatelli F, Alberti D, et al: Hypertension as a factor in chronic renal insufficiency progression in polycystic kidney disease. The Northern Italian Cooperative Study Group. Nephrol Dial Transplant 1995;10(suppl 6):15-17.
73. O'Connell MB, Madden DM, Murray AM, Heaney RP, Kerzner LJ: Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med 2005;118:778-781.
74. Maier GW, Kreis ME, Zittel TT, Becker HD: Calcium regulation and bone mass loss after total gastrectomy in pigs. Ann Surg 1997;225:181-192.
75. Glatzle J, Piert M, Meile T, et al: Prevalence of vertebral alterations and the effects of calcium and vitamin D supplementation on calcium metabolism and bone mineral density after gastrectomy. Br J Surg 2005;92:579-585.
76. Zittel TT, Zeeb B, Maier GW, et al: High prevalence of bone disorders after gastrectomy. Am J Surg 1997;174:431-438.
77. Persson P, Gagnemo-Persson R, Chen D, et al: Gastrectomy causes bone loss in the rat: is lack of gastric acid responsible? Scand J Gastroenterol 1993;28:301-306.
78. +-ATPase, on bone resorption in humans. Calcif Tissue Int 1993;53:21-25.
79. +-ATPase, inhibits bone resorption in vitro. Calcif Tissue Int 1986;38:123-125.
80. Bezwoda W, Charlton R, Bothwell T, Torrance J, Mayet F: The importance of gastric hydrochloric acid in the absorption of nonheme food iron. J Lab Clin Med 1978;92:108-116.
81. Conrad ME, Schade SG: Ascorbic acid chelates in iron absorption: a role for hydrochloric acid and bile. Gastroenterology 1968;55:35-45.
82. Cook JD, Brown GM, Valberg LS: The effect of achylia gastrica on iron absorption. J Clin Invest 1964;43:1185-1191.
83. Goldberg A, Lochhead AC, Dagg JH: Histamine-fast achlorhydria and iron absorption. Lancet 1963;1:848-850.
84. Schade SG, Cohen RJ, Conrad ME: Effect of hydrochloric acid on iron absorption. N Engl J Med 1968;279:672-674.
85. Lochhead AC, Goldberg A: Mechanisms in the transfer of protein-bound iron for haem biosynthesis. Clin Sci 1963;24:229-237.
86. Wheldon EJ, Venables CW, Johnston ID: The relationship of gastric secretion to anemia over 15 years following vagotomy and gastroenterostomy. Gut 1970;11:1056.
87. Wheldon EJ, Venables CW, Johnston ID: Late metabolic sequelae of vagotomy and gastroenterostomy. Lancet 1970;1:437-440.
88. Carmel R, Perez-Perez GI, Blaser MJ: Helicobacter pylori infection and food-cobalamin malabsorption. Dig Dis Sci 1994;39:309-314.
89. Cater RE 2nd: The clinical importance of hypochlorhydria (a consequence of chronic Helicobacter infection): its possible etiological role in mineral and amino acid malabsorption, depression, and other syndromes. Med Hypotheses 1992;39:375-383.
90. Jensen RT: Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas. Basic Clin Pharmacol Toxicol 2006;98:4-19.
91. 12. Dig Dis Sci 1979;24:397-402.
92. 12 after vagotomy. Am J Surg 1974;128:340-343.
93. 12 in patients with hypochlorhydria and achlorhydria and after gastric resection. Gastroenterology 1973;64:913-919.
94. 12 concentration. Scand J Gastroenterol 1977;12:313-319.
95. Mahmud K, Ripley D, Swaim WR, Doscherholmen A: Hematologic complications of partial gastrectomy. Ann Surg 1973;177:432-435.
96. 12. Scand J Gastroenterol 1982;17:129-131.
97. 12 concentration after proximal gastric vagotomy. Scand J Gastroenterol 1984;19:445-448.
98. Whittingham S, Mackay IR: Autoimmune gastritis: historical antecedents, outstanding discoveries, and unresolved problems. Int Rev Immunol 2005;24:1-29.
99. Schubert ML: Gastric secretion. Curr Opin Gastroenterol 2003;19:519-525.
100. Jeffries GH, Weser E, Sleisenger MH: Malabsorption. Gastroenterology 1964;46:434-466.
101. Toffolon EP, Goldfinger SE: Malabsorption following gastrectomy and ileal resection. Surg Clin North Am 1974;54:647-653.
102. Kinoshita Y, Hassan MS, Kawamura M, et al: Increased hepatocyte growth factor content in rat stomach during omeprazole treatment. Digestion 1998;59:102-109.
103. Brabletz T, Spaderna S, Kolb J, et al: Down-regulation of the homeodomain factor CDx2 in colorectal cancer by collagen type I: an active role for the tumor environment in malignant tumor progression. Cancer Res 2004;64:6973-6977.
104. Faller G, Dimmler A, Rau T, et al: Evidence for acid-induced loss of CDx2 expression in duodenal gastric metaplasia. J Pathol 2004;203:904-908.
105. Faller G, Kirchner T: Immunological and morphogenic basis of gastric mucosa atrophy and metaplasia. Virchows Arch 2005;446:1-9.
106. Creutzfeldt WC, Blum AL: Safety of omeprazole. Lancet 1994;343:1098.
107. Marchetti M, Caliot E, Pringault E: Chronic acid exposure leads to activation of the CDx2 intestinal homeobox gene in a long-term culture of mouse esophageal keratinocytes. J Cell Sci 2003;116:1429-1436.
108. Lamberts R, Creutzfeldt W, Struber HG, Brunner G, Solcia E: Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology 1993;104:1356-1370.
109. Howden CW, Hunt RH: Relationship between gastric secretion and infection. Gut 1987;28:96-107.
110. Bik EM, Eckburg PB, Gill SR, et al: Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci USA 2006;103:732-737.
111. Drasar BS, Hughes WH, Williams RE, Shiner M: Bacterial flora of the normal intestine. Proc R Soc Med 1966;59:1243.
112. Drasar BS, Shiner M, McLeod GM: Studies on the intestinal flora. 1. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons. Gastroenterology 1969;56:71-79.
113. Franklin MA, Skoryna SC: Studies on natural gastric flora. 1. Bacterial flora of fasting human subjects. Can Med Assoc J 1966;95:1349-1355.
114. Stockbruegger RW, Cotton PB, Menon GG, et al: Pernicious anaemia, intragastric bacterial overgrowth, and possible consequences. Scand J Gastroenterol 1984;19:355-364.
115. Brummer RJ, Stockbrugger RW: Effect of nizatidine 300 mg at night and omeprazole 20 mg in the morning on 24-hour intragastric pH and bacterial overgrowth in patients with acute duodenal ulcer. Dig Dis Sci 1996;41:2048-2054.
116. Thomas JM, Misiewicz JJ, Cook AR, et al: Effects of one year's treatment with ranitidine and of truncal vagotomy on gastric contents. Gut 1987;28:726-738.
117. Winter TA, Marks T, Callanan M, O'Keefe SJ, Bridger S: Impaired pancreatic secretion in severely malnourished patients is a consequence of primary pancreatic dysfunction. Nutrition 2001;17:230-235.
118. Thorens J, Froehlich F, Schwizer W, et al: Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut 1996;39:54-59.
119. Sanduleanu S, Jonkers D, De Bruine A, Hameeteman W, Stockbrugger RW: Non- Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa. Aliment Pharmacol Ther 2001;15:379-388.
120. Sanduleanu S, Jonkers D, De Bruine A, Hameeteman W, Stockbrugger RW: Double gastric infection with Helicobacter pylori and non- Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis. Aliment Pharmacol Ther 2001;15:1163-1175.
121. Williams C: Occurrence and significance of gastric colonization during acid-inhibitory therapy. Best Pract Res Clin Gastroenterol 2001;15:511-521.
122. Bourne JT, Mountford RA, Barry RE: Twice-daily cimetidine does not increase gastric bacterial flora. Postgrad Med J 1984;60:464-466.
123. Ruddell WS, Axon AT, Findlay JM, Bartholomew BA, Hill MJ: Effect of cimetidine on the gastric bacterial flora. Lancet 1980;1:672-674.
124. Reed PI, Smith PL, Haines K, House FR, Walters CL: Effect of cimetidine on gastric juice N-nitrosamine concentration. Lancet 1981;2:553-556.
125. Stockbrugger RW, Cotton PB, Eugenides N, Bartholomew BA, Hill MJ, Walters CL: Intragastric nitrites, nitrosamines, and bacterial overgrowth during cimetidine treatment. Gut 1982;23:1048-1054.
126. Snepar R, Poporad GA, Romano JM, Kobasa WD, Kaye D: Effect of cimetidine and antacid on gastric microbial flora. Infect Immun 1982;36:518-524.
127. Milton-Thompson GJ, Lightfoot NF, Ahmet Z, et al: Intragastric acidity, bacteria, nitrite, and N-nitroso compounds before, during, and after cimetidine treatment. Lancet 1982;1:1091-1095.
128. Garcia del Risco F, Rolin O, Farinotti R, et al: Influence of ranitidine during a 24-hour period on the level of nitrites, nitrates, nitrosamines and bacterial flora in the gastric juice of healthy subjects (in French). Gastroenterol Clin Biol 1984;8:749-753.
129. Amin N: Giardiasis: a common cause of diarrheal disease. Postgrad Med 1979;66:151-156, 158.
130. Gray JD, Shiner M: Influence of gastric pH on gastric and jejunal flora. Gut 1967;8:74-81.
131. Giannella RA, Broitman SA, Zamcheck N: Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro. Gut 1972;13:251-256.
132. Dellipiani AW, Girdwood RH: Bacterial changes in the small intestine in malabsorptive states and in pernicious anaemia. Clin Sci 1964;26:359-374.
133. Mowat C, Williams C, Gillen D, et al: Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation. Gastroenterology 2000;119:339-347.
134. Sharma BK, Santana IA, Wood EC, et al: Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. Br Med J (Clin Res Ed) 1984;289:717-719.
135. Verdu E, Viani F, Armstrong D, et al: Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds. Gut 1994;35:455-460.
136. Viani F, Siegrist HH, Pignatelli B, et al: The effect of intra-gastric acidity and flora on the concentration of N-nitroso compounds in the stomach. Eur J Gastroenterol Hepatol 2000;12:165-173.
137. Glupczynski Y: Prolonged gastric acid suppression therapy: a significant risk factor for Listeria monocytogenes infection? Eur J Gastroenterol Hepatol 1996;8:1063-1066.
138. Toeg A, Berger SA, Battat A, Hoffman M, Yust I: Vibrio cholerae bacteremia associated with gastrectomy. J Clin Microbiol 1990;28:603-604.
139. Theisen J, Nehra D, Citron D, et al: Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. J Gastrointest Surg 2000;4:50-54.
140. Williams C, McColl KE: Review article: proton pump inhibitors and bacterial over-growth. Aliment Pharmacol Ther 2006;23:3-10.
141. Winter JW, Paterson S, Scobie G, Wirz A, Preston T, McColl KE: N-nitrosamine generation from ingested nitrate via nitric oxide in subjects with and without gastroesophageal reflux. Gastroenterology 2007;133:164-174.
142. Moriya A, Grant J, Mowat C, et al: In vitro studies indicate that acid catalysed generation of N-nitrosocompounds from dietary nitrate will be maximal at the gastro-oesophageal junction and cardia. Scand J Gastroenterol 2002;37:253-261.
143. Yeomans ND, Brimblecombe RW, Elder J, et al: Effects of acid suppression on microbial flora of upper gut. Dig Dis Sci 1995;40(2 suppl):81S-95S.
144. Larner AJ, Hamilton MI: Review article: infective complications of therapeutic gastric acid inhibition. Aliment Pharmacol Ther 1994;8:579-584.
145. Kaneko H, Konagaya T, Kusugami K: Helicobacter pylori and gut hormones. J Gastroenterol 2002;37:77-86.
146. Shimatani T, Inoue M, Iwamoto K, et al: Gastric acidity in patients with follicular gastritis is significantly reduced, but can be normalized after eradication for Helicobacter pylori. Helicobacter 2005;10:256-265.
147. Tsai SH, Chen CM, Chang CS, Chen GH: Effect of Helicobacter pylori infection on intragastric acidity in patients with reflux esophagitis. J Gastroenterol 2004;39:821-826.
148. Vollaard AM, Verspaget HW, Ali S, et al: Helicobacter pylori infection and typhoid fever in Jakarta, Indonesia. Epidemiol Infect 2006;134:163-170.
149. Clemens J, Albert MJ, Rao M, et al: Impact of infection by Helicobacter pylori on the risk and severity of endemic cholera. J Infect Dis 1995;171:1653-1656.
150. Fried M, Siegrist H, Frei R, et al: Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut 1994;35:23-26.
151. Cook GC: Infective gastroenteritis and its relationship to reduced gastric acidity. Scand J Gastroenterol Suppl 1985;111:17-23.
152. Giannella RA, Broitman SA, Zamcheck N: Influence of gastric acidity on bacterial and parasitic enteric infections. A perspective. Ann Intern Med 1973;78:271-276.
153. Martinsen TC, Bergh K, Waldum HL: Gastric juice: a barrier against infectious diseases. Basic Clin Pharmacol Toxicol 2005;96:94-102.
154. Laine L, Ahnen D, McClain C, Solcia E, Walsh JH: Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther 2000;14:651-668.
155. Neal KR, Scott HM, Slack RC, Logan RF: Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study. BMJ 1996;312:414-415. 156 Neal K, Logan R: Potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther 2001;15:1085-1086.
156. Canani RB, Cirillo P, Roggero P, et al: Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics 2006;117:e817-e820.
157. Kunz LJ, Waddell WR: Association of Salmonella enteritis with operations on the stomach. N Engl J Med 1956;255:555-559.
158. Giannella RA, Broitman SA, Zamcheck N: Salmonella enteritis. 1. Role of reduced gastric secretion in pathogenesis. Am J Dig Dis 1971;16:1000-1006.
159. Doorduyn Y, Van Den Brandhof WE, Van Duynhoven YT, Wannet WJ, Van Pelt W: Risk factors for Salmonella enteritidis and Typhimurium (DT104 and non-DT104) infections in The Netherlands: predominant roles for raw eggs in enteritidis and sand-boxes in Typhimurium infections. Epidemiol Infect 2006;134:617-626.
160. Cunningham R, Dale B, Undy B, Gaunt N: Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect 2003;54:243-245.
161. Dial S, Alrasadi K, Manoukian C, Huang A, Menzies D: Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ 2004;171:33-38.
162. Dial S, Delaney JA, Barkun AN, Suissa S: Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005;294:2989-2995.
163. Dial S, Delaney JA, Schneider V, Suissa S: Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. CMAJ 2006;175:745-748.
164. Potter RC, Kaneene JB, Hall WN: Risk factors for sporadic Campylobacter jejuni infections in rural Michigan: a prospective case-control study. Am J Public Health 2003;93:2118-2123.
165. Konturek SJ, Bielanski W, Solomon TE: Effects of an antral mucosectomy, L-364,718 and atropine on cephalic phase of gastric and pancreatic secretion in dogs. Gastroenterology 1990;98:47-55.
166. Ariyasu H, Takaya K, Tagami T, et al: Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001;86:4753-4758.
167. Date Y, Kojima M, Hosoda H, et al: Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000;141:4255-4261.
168. Cowley MA, Smith RG, Diano S, et al: The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003;37:649-661.
169. Campbell BJ, Dimaline R, Dockray GJ, Hughes J: Inhibition of food intake by omeprazole in the chicken. Eur J Pharmacol 1991;209:231-235.
170. Nakazato M, Murakami N, Date Y, et al: A role for ghrelin in the central regulation of feeding. Nature 2001;409:194-198.
171. Wren AM, Seal LJ, Cohen MA, et al: Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001;86:5992.
172. Winter TA, O'Keefe S J, Callanan M, Marks T: Impaired gastric acid and pancreatic enzyme secretion in patients with Crohn's disease may be a consequence of a poor nutritional state. Inflamm Bowel Dis 2004;10:618-625.
173. Wisen O, Rossner S, Johansson C: Gastric secretion in massive obesity. Evidence for abnormal response to vagal stimulation. Dig Dis Sci 1987;32:968-972.
174. Granstrom L, Backman L: Gastric acid secretion in extremely obese subjects before and after gastric banding. Acta Chir Scand 1987;153:105-108.
175. Magni G, Rizzardo R, Di Mario F, Farini R, Aggio L, Naccarato R: Personality and psychological factors in chronic duodenal ulcer. Their interaction with biological parameters. Schweiz Arch Neurol Neurochir Psychiatr 1984;135:315-320.
176. Bresnick WH, Rask-Madsen C, Hogan DL, Koss MA, Isenberg JI: The effect of acute emotional stress on gastric acid secretion in normal subjects and duodenal ulcer patients. J Clin Gastroenterol 1993;17:117-122.
177. Feldman M, Walker P, Goldschmiedt M, Cannon D: Role of affect and personality in gastric acid secretion and serum gastrin concentration. Comparative studies in normal men and in male duodenal ulcer patients. Gastroenterology 1992;102:175-180.
178. Jess P: Gastric acid secretion in relation to personality, affect and coping ability in duodenal ulcer patients. A multivariate analysis. Hvidovre Ulcer Project Group. Dan Med Bull 1994;41:100-103.
179. Wright CE, Ebrecht M, Mitchell R, Anggiansah A, Weinman J: The effect of psychological stress on symptom severity and perception in patients with gastro-oesophageal reflux. J Psychosom Res 2005;59:415-424.
180. McDonald-Haile J, Bradley LA, Bailey MA, Schan CA, Richter JE: Relaxation training reduces symptom reports and acid exposure in patients with gastroesophageal reflux disease. Gastroenterology 1994;107:61-69.
181. Holtmann G, Singer MV, Kriebel R, Stacker KH, Goebell H: Differential effects of acute mental stress on interdigestive secretion of gastric acid, pancreatic enzymes, and gastroduodenal motility. Dig Dis Sci 1989;34:1701-1707.
182. Kern M, Hofmann C, Hyde J, Shaker R: Characterization of the cerebral cortical representation of heartburn in GERD patients. Am J Physiol Gastrointest Liver Physiol 2004;286:G174-G181.
183. Glavin GB, Hall AM: Central nervous system and gut interactions: dopamine and experimental gastroduodenal lesions. J Gastroenterol Hepatol 1994;9(suppl 1):S36-S39.
184. Kern W, Schiefer B, Schwarzenburg J, Stange EF, Born J, Fehm HL: Evidence for central nervous effects of corticotropin-releasing hormone on gastric acid secretion in humans. Neuroendocrinology 1997;65:291-298.
185. Kato K, Murai I, Asai S, et al: Central nervous system action of melatonin on gastric acid and pepsin secretion in pylorus-ligated rats. Neuroreport 1998;9:3989-3992.
186. Nomura K, Maeda N, Yoshino T, Yamaguchi I: A mechanism of 5-HT 3 receptor mediation is involved etiologically in the psychological stress lesion the stomach of the mouse. J Pharmacol Exp Ther 1994;271:100-106.
187. Ma J, Vaillancourt R, Boddam R, Auger S, Sampalis J: Association between antidepressant use and prescribing of gastric acid suppressants. Can J Psychiatry 2006;51:178-184.
188. Padmos RC, Bekris L, Knijff EM, et al: A high prevalence of organ-specific autoimmunity in patients with bipolar disorder. Biol Psychiatry 2004;56:476-482.
189. Fireman Z, Kopelman Y, Sternberg A: Central nervous system side effects after proton pump inhibitor treatment. J Clin Gastroenterol 1997;25:718.
190. +-ATPase (proton pump) inhibitors dampen increased cough reflex: more than gastric acid suppression. Clin Exp Allergy 2005;35:245-246.